Quantinuum Scores $600M at $10B Valuation - Nvidia and JPMorgan Back Honeywell Spinout, IPO Slated 2027

Quantum unit Quantinuum, spun out of Honeywell, has just pulled in about $600 million at a $10 billion valuation - a neat doubling from its $5 billion mark in January 2024. The round included new money from Quanta Computer (TWSE: 2382.TW), QED Investors and NVentures, the venture arm of NVIDIA (NASDAQ: NVDA). Existing backers such as JPMorgan Chase (NYSE: JPM) and Mitsui also participated, with parent company Honeywell (NYSE: HON) remaining the majority owner.

That $10 billion tag is getting attention because it signals continued appetite for quantum plays from both tech and finance capital. Nvidia's involvement isn't just a cash vote; the chipmaker has been building out quantum work in Boston and is already partnering with firms like Quantinuum on research. For NVDA, the bet is a strategic one - tying classical GPU stacks and AI tooling to early-stage quantum hardware and software.

Quantinuum has been openly preparing for a spin-off and an eventual IPO, with Honeywell's CEO flagging a target of "by the end of 2027." An injection of this size helps finance product development, scale partnerships and make the company look cleaner to public markets when the paperwork starts. It also shaves risk off the timeline: more capital means a longer runway and more leverage in selecting an IPO window.

From a valuation perspective, doubling in roughly 18 months suggests that private-market investors are treating quantum computing as more than a speculative niche. That said, $10 billion for a quantum software-plus-hardware player still carries longer-term execution questions - commercial proof points remain limited and timelines can slip.

How this reverberates across equities is straightforward to map: the headline will be noticed by holders of HON, NVDA and financial backers like JPM. For Nvidia, the deal reinforces its positioning as a bridge between current AI compute and next-gen quantum systems. For Honeywell, spinning Quantinuum into a stand-alone public company could reframe parts of its balance sheet and investor story down the line.

There's also a competitive angle. Big tech and chipmakers are jockeying for early relationships with quantum incumbents; tying up capital and labs now can secure future software hooks and customer pipelines. Whether those early ties convert into revenue at scale is still an open question.

Quantinuum's new valuation is a clear marker of where private capital thinks quantum is headed - and it gives a concrete timeline to watch as the company preps for an IPO slated for 2027. For now, it's a reminder that quantum is moving from lab experiments to market-facing companies with serious financing behind them.